Delivery Order SPE2DB22D1017-SPE2DB25FYSBQ
- Not listed
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.55 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) under a firm fixed price contract type. This non-set-aside award was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, and the place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $15,238.68 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,689.68 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) on March 4, 2025, with a completion date of March 5, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $27,153.26 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract, effective August 5, 2025, with a completion date of August 6, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSBQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,710.41 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial role as a critical pharmaceutical supplier to federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent success in competitive procurement across multiple therapeutic domains, with delivery orders ranging substantially in value and supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/26/25 |